Respiratory syncytial virus infections has been the subject of sustained clinical investigation across multiple research sites.

25 total trials for this combination

Showing top 10 of 25 trials

Trials

NCT ID	Title	Status	Phase
NCT02325791	Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants	COMPLETED	PHASE3
NCT03656510	Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection	TERMINATED	PHASE2
NCT02878330	A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.	COMPLETED	PHASE2
NCT03979313	A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)	COMPLETED	PHASE3
NCT04056611	Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)	TERMINATED	PHASE2
NCT03959488	A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children	COMPLETED	PHASE2/PHASE3
NCT04633187	Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract	TERMINATED	PHASE2
NCT02624947	A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization	COMPLETED	PHASE3
NCT02984280	Specific Respiratory Infections as Triggers of Acute Medical Events	COMPLETED	—
NCT02202356	A Study of ALS-008176 in Infants Hospitalized With RSV	COMPLETED	PHASE1

Related Pages

All Respiratory syncytial virus infections trials All trials in London, United Kingdom